Provexis PLC (PXS)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

0.55p

Buy

0.70p

arrow-down-0.065p (-9.63%)

Prices updated at 03 Jun 2024, 15:30 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Provexis PLC is engaged in developing and licensing the proprietary Fruitflow, which is a heart-health functional food ingredient for the functional food sector.
FTSE All-Share
arrow-up0.2%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
0.68
triangle-d
arrow-down
-0.07 (-11.11%)
triangle-d
Today open
0.60
triangle-d
arrow-up
0.04 (+7.33%)
triangle-d
Today, 15:30:05 BST
0.64
triangle-d
0.75p - 0.60p
0.90p - 0.41p
-
15.27m
-
750,000
1,561,465
15.54
919,381.80
0.56
2,217.82m
GB00B0923P27
0.00
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.